Erasable serum markers

Area of Science:

• Neuroscience
• Biotechnology
• Molecular Biology

Background:

• Brain gene expression analysis typically requires invasive methods like biopsy or postmortem histology.
• Existing serum markers for brain monitoring are limited, lack specific cellular localization, and are affected by long half-lives for dynamic tracking.

Purpose of the Study:

• To develop a non-invasive method for sensitive and dynamic monitoring of brain gene expression using serum markers.
• To overcome the limitations of long serum half-lives in current serum markers for tracking temporal changes.

Main Methods:

• Engineered "on-demand erasable released markers of activity" (RMAs) for transgene expression measurement.
• Utilized an intravenous targeted protease to reduce RMA background signal.
• Validated the system's sensitivity in detecting expression from as few as 12 neurons in mice.

Main Results:

• The engineered RMAs demonstrated a >100-hour serum half-life and detected expression from minimal neuronal populations.
• Erasable RMAs, combined with protease injection, reduced background signal by over an order of magnitude.
• The system achieved a 65,000-fold signal increase and improved dynamic range for detecting low-level promoter activity.

Conclusions:

• Erasable RMAs offer a sensitive and non-invasive approach to monitor brain gene expression through simple blood tests.
• This technology enhances the dynamic range for tracking gene expression, particularly for low-level promoter activity relevant to physiological states like c-Fos.
• The developed system represents a significant advancement for studying brain activity and gene regulation non-invasively.